Paper6182020
Normal immunosuppressive protein: inhibitory effect on hemagglutinin and plaque formation as well as B cell transformation by Epstein-Barr virus.
Nelken D and 1 other. Experientia, 1982. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Normal immunosuppressive protein: inhibitory effect on hemagglutinin and plaque formation as well as B cell transformation by Epstein-Barr virus. Papers, record 6182020. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6182020
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Normal immunosuppressive protein: inhibitory effect on hemagglutinin and plaque formation as well as B cell transformation by Epstein-Barr virus.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alpha-Globulins | Major topic |
| B-Lymphocytes | Major topic |
| Hemagglutinins | Major topic |
| Herpesvirus 4, Human | Major topic |
| Lymphocyte Activation | Major topic |
| Animals | |
| Erythrocytes | |
| Fetal Blood | |
| Hemolytic Plaque Technique | |
| Humans | |
| Rats |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4120227 | Alpha globulin decreases resistance of mice to infection with group A Streptococcus. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4120227 | PubMed |
| 2 | 59440 | Humoral immunosuppressive factors. | Transplant Proc | 1976 | https://conductscience.org/library/papers/59440 | PubMed |
| 3 | 5954775 | Antibody production studied by means of the LHG assay. I. The splenic response of CBA mice to sheep erythrocytes. | Immunology | 1966 | https://conductscience.org/library/papers/5954775 | PubMed |
| 4 | 86450 | Normal immunosuppressive protein inhibition of human and murine lymphoblastoid cell line proliferation. | Eur J Immunol | 1979 | https://conductscience.org/library/papers/86450 | PubMed |
| 5 | 51828 | Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein. | Immunology | 1975 | https://conductscience.org/library/papers/51828 | PubMed |
| 6 | 4357682 | Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. | J Exp Med | 1973 | https://conductscience.org/library/papers/4357682 | PubMed |
| 7 | 7439928 | Normal immunosuppressive protein. Isolation of a glycoprotein active fraction. | Immunology | 1980 | https://conductscience.org/library/papers/7439928 | PubMed |
| 8 | 51798 | Effect of Normal Immunosuppressive Protein (NIP) on tumor growth in mice. | Eur J Cancer (1965) | 1975 | https://conductscience.org/library/papers/51798 | PubMed |
| 9 | 479607 | Normal immunosuppressive protein purification and quantitative estimation experiments. | J Immunol Methods | 1979 | https://conductscience.org/library/papers/479607 | PubMed |
| 10 | 79543 | Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells. | Immunology | 1978 | https://conductscience.org/library/papers/79543 | PubMed |
| 11 | 6162784 | The inhibitory effect of normal immunosuppressive protein on lymphocytes mediating natural killing activity. | Immunology | 1981 | https://conductscience.org/library/papers/6162784 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6182020
GET https://conductscience.org/api/papers/v1/6182020/authors